Layton Patrick Mills
Founder at CANNPAL ANIMAL THERAPEUTICS LIMITED
Profile
Layton Patrick Mills is the founder of CannPal Animal Therapeutics Ltd., a company founded in 2016.
He holds the title of Chief Executive Officer, Director & MD at CannPal Animal Therapeutics Ltd.
Currently, Mr. Mills is a Non-Executive Director at Argent BioPharma Ltd., a position he started in 2023.
In the past, he served as the Chief Executive Officer at AusCann Group Holdings Ltd.
from 2021 to 2022.
Layton Patrick Mills active positions
| Companies | Position | Start |
|---|---|---|
| CANNPAL ANIMAL THERAPEUTICS LIMITED | Founder | 02/06/2016 |
| ARGENT BIOPHARMA LIMITED | Director/Board Member | 31/05/2023 |
Former positions of Layton Patrick Mills
| Companies | Position | End |
|---|---|---|
| AUSCANN GROUP HOLDINGS LTD | Chief Executive Officer | 12/09/2022 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ARGENT BIOPHARMA LIMITED | Health Technology |
| AUSCANN GROUP HOLDINGS LTD | Process Industries |
| Private companies | 1 |
|---|---|
CannPal Animal Therapeutics Ltd.
 CannPal Animal Therapeutics Ltd. Pharmaceuticals: OtherHealth Technology CannPal Animal Therapeutics Ltd. pharmaceutical company, which focuses on animal health. It researches, develops, and commercializes regulatory approved cannabinoid-derived therapeutic pet products for cats and dogs. The company was founded by Layton Mills on June 3, 2016 and is headquartered in Double Bay, Australia. | Health Technology |
- Stock Market
- Insiders
- Layton Patrick Mills
